These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22246967)

  • 1. Incomplete revascularization: appropriate and inappropriate.
    Taggart DP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):542-3. PubMed ID: 22246967
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of coronary artery disease in the year 2003.
    Fleisher LA; Barash PG
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):258-9. PubMed ID: 12698413
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention versus coronary-artery bypass grafting.
    Shil AB; Aung T; Strohm MP
    N Engl J Med; 2009 Jun; 360(25):2673-4; author reply 2674-5. PubMed ID: 19537316
    [No Abstract]   [Full Text] [Related]  

  • 5. The Gordian knot of revascularization for multivessel coronary artery disease.
    Takagi H; Manabe H; Umemoto T
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):241-2; author reply 242-3. PubMed ID: 21683848
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary artery disease: Risk models for revascularization--the search continues.
    Park SJ; Lee CW
    Nat Rev Cardiol; 2012 Apr; 9(6):316-8. PubMed ID: 22507970
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial revascularization: surgery or stenting?
    Wong SH; Wan S; Underwood MJ
    Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):264-9. PubMed ID: 17541004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SYNTAX score and SYNTAX-based clinical risk scores.
    Farooq V; Brugaletta S; Serruys PW
    Semin Thorac Cardiovasc Surg; 2011; 23(2):99-105. PubMed ID: 22041038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does percutaneous coronary intervention compromise the outcome of subsequent coronary artery bypass grafting?
    Mack M
    JACC Cardiovasc Interv; 2009 Aug; 2(8):765-6. PubMed ID: 19695545
    [No Abstract]   [Full Text] [Related]  

  • 10. eComment: Endothelin-1 correlation with myocardial injury and no-reflow phenomenon.
    Koniari I; Michalopoulos A
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):589-90. PubMed ID: 22144647
    [No Abstract]   [Full Text] [Related]  

  • 11. Class I indications for coronary artery bypass graft surgery: what is the appropriate therapy for patients with multivessel coronary disease?
    Dean LS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):622-3. PubMed ID: 19628184
    [No Abstract]   [Full Text] [Related]  

  • 12. How should stable coronary artery disease be managed in the modern era?
    Woollard KV; Newman MA
    Med J Aust; 2007 Aug; 187(3):140-1. PubMed ID: 17680737
    [No Abstract]   [Full Text] [Related]  

  • 13. Left anterior descending coronary artery revascularization patient-tailored therapy?
    Abbate A; Vetrovec GW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):492-3. PubMed ID: 19463350
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing procedural risks to select the optimal revascularization strategy: certainty in an uncertain anatomical world.
    Hoole SP; Hamburger JN
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):313-4. PubMed ID: 20853370
    [No Abstract]   [Full Text] [Related]  

  • 15. Competing risk analysis of events 10 years after revascularization.
    Melberg T; Nygård OK; Kuiper KK; Nordrehaug JE
    Scand Cardiovasc J; 2010 Oct; 44(5):279-88. PubMed ID: 20524905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transradial access: just do it!
    Mann T
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1065-6. PubMed ID: 19926045
    [No Abstract]   [Full Text] [Related]  

  • 17. Pitfalls assessing the role of drug-eluting stents in multivessel coronary disease.
    Desai ND
    Ann Thorac Surg; 2008 Jan; 85(1):25-7. PubMed ID: 18154771
    [No Abstract]   [Full Text] [Related]  

  • 18. Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
    Delhaye C; Sudre A; Lemesle G; Vanesson L; Koussa M; Fayad G; Bauters C; Lablanche JM; Modine T
    Arch Cardiovasc Dis; 2010 Oct; 103(10):502-11. PubMed ID: 21130963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention "dominates" coronary artery bypass graft surgery for high-risk patients: good news for patients, a challenge for healthcare planners.
    Radford MJ
    Circulation; 2006 Sep; 114(12):1229-31. PubMed ID: 16982950
    [No Abstract]   [Full Text] [Related]  

  • 20. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.